Inge‐Britt Lindén

Author

Inge‐Britt Lindén

Also Known As

I B Lindén, I. -B. Lindén, I.-B Linden, I.-B. Linden, I.-B. Lindén, I.‐B. LINDEN, I.‐B. Lindén, Inge Britt Linden, Inge-Britt Linden, Inge-Britt Lindén

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Orion Corporation (Finland)Tampere University University of Helsinki Helsinki University Hospital

About

Inge‐Britt Lindén is an author at Orion Corporation (Finland) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	899
2	Natural Sciences	4	4	300
3	Health Sciences	1	1	12
4	Social Sciences	1	1	17
5	Allergy	1	1	32

Inge‐Britt Lindén

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation Heimo Haikala, Erkki Nissinen, E Etemadzadeh, Journal of Cardiovascular Pharmacology Cardiac MuscleMuscle FunctionSynaptic TransmissionCytoskeletonMechanotransduction	1995	226
Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone Erkki Nissinen, Inge‐Britt Lindén, Eija Schultz, Naunyn-Schmiedeberg s Archives of Pharmacology Catechol-o-methyltransferase Inhibitor EntacaponeBiochemistryMedicinePharmacological PropertiesMechanism Of Action	1992	146
Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors Reijo Bäckström, Erkki Honkanen, Aino Pippuri, Journal of Medicinal Chemistry	1989	144
Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat Erkki Nissinen, Inge‐Britt Lindén, Eija Schultz, European Journal of Pharmacology BiochemistryCatechol-o-methyltransferase ActivityCatabolismPharmacologyInhibitory Activity	1988	115
Mechanisms of Action of Calcium-Sensitizing Drugs Heimo Haikala, Inge‐Britt Lindén Journal of Cardiovascular Pharmacology Muscle FunctionEmd 53998CytoskeletonPharmacotherapyMechanotransduction	1995	115
Mechanisms of Action of Calcium-Sensitizing Drugs Heimo Haikala, Inge‐Britt Lindén Journal of Cardiovascular Pharmacology Muscle FunctionEmd 53998CytoskeletonPharmacotherapyMechanotransduction	1995	112
Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production Erkki Nissinen, Petri Kaheinen, Kai E. Penttilä, European Journal of Pharmacology Novel Catechol-o-methyltransferase InhibitorMitochondrial FunctionBiochemistryMedicineNeuropharmacology	1997	69
Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase Pekka T. Männistö, Seppo Kaakkola, Erkki Nissinen, Life Sciences Medicinal ChemistryBiochemistryNatural SciencesMedicineSelective Inhibitors	1988	58
Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease. Inge‐Britt Lindén, Erkki Nissinen, E Etemadzadeh, Journal of Pharmacology and Experimental Therapeutics	1988	49
Inhibition of Prostaglandin Biosynthesis by Tolfenamic Acid in Vitro Inge‐Britt Lindén, J. Parantainen, Heikki Vapaatalo Scandinavian Journal of Rheumatology	1976	48

Page 1